Arkolith/Insider Trading/WHWK/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed May 18, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Grant(A)51K$3.92$200K570K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001995275-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML